Literature DB >> 27628529

miR-137 and miR-491 Negatively Regulate Dopamine Transporter Expression and Function in Neural Cells.

Xiaojian Jia1, Feng Wang1,2, Ying Han3, Xuewen Geng1, Minghua Li1, Yu Shi1, Lin Lu4, Yun Chen5.   

Abstract

The dopamine transporter (DAT) is involved in the regulation of extracellular dopamine levels. A 40-bp variable-number tandem repeat (VNTR) polymorphism in the 3'-untranslated region (3'UTR) of the DAT has been reported to be associated with various phenotypes that are involved in the aberrant regulation of dopaminergic neurotransmission. In the present study, we found that miR-137 and miR-491 caused a marked reduction of DAT expression, thereby influencing neuronal dopamine transport. Moreover, the regulation of miR-137 and miR-491 on this transport disappeared after the DAT was silenced. The miR-491 seed region that is located on the VNTR sequence in the 3'UTR of the DAT and the regulatory effect of miR-491 on the DAT depended on the VNTR copy-number. These data indicate that miR-137 and miR-491 regulate DAT expression and dopamine transport at the post-transcriptional level, suggesting that microRNA may be targeted for the treatment of diseases associated with DAT dysfunction.

Entities:  

Keywords:  3′-Untranslated region; Dopamine transporter; Posttranscriptional regulation; Solute carrier family 6 member 3; Variable-number tandem repeat; hsa-miR-137; hsa-miR-491-5p

Mesh:

Substances:

Year:  2016        PMID: 27628529      PMCID: PMC5563834          DOI: 10.1007/s12264-016-0061-6

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  54 in total

1.  Association between the 9 repeat allele of the dopamine transporter 40bp variable tandem repeat polymorphism and Alzheimer's disease.

Authors:  Ágnes Fehér; Anna Juhász; Magdolna Pákáski; János Kálmán; Zoltán Janka
Journal:  Psychiatry Res       Date:  2014-07-31       Impact factor: 3.222

Review 2.  Neurotransmitter transporters and their impact on the development of psychopharmacology.

Authors:  Leslie Iversen
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

3.  The atypical dopamine transport inhibitor, JHW 007, prevents amphetamine-induced sensitization and synaptic reorganization within the nucleus accumbens.

Authors:  Clara Velázquez-Sánchez; José M García-Verdugo; Juan Murga; Juan J Canales
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-02-04       Impact factor: 5.067

Review 4.  Regulation of dopamine transporter function by protein-protein interactions: new discoveries and methodological challenges.

Authors:  Jacob Eriksen; Trine Nygaard Jørgensen; Ulrik Gether
Journal:  J Neurochem       Date:  2010-01-18       Impact factor: 5.372

Review 5.  Molecular, functional and biochemical characteristics of the dopamine transporter: regional differences and clinical relevance.

Authors:  A Hitri; Y L Hurd; R J Wyatt; S I Deutsch
Journal:  Clin Neuropharmacol       Date:  1994-02       Impact factor: 1.592

6.  Substrate-modulated gating dynamics in a Na+-coupled neurotransmitter transporter homologue.

Authors:  Yongfang Zhao; Daniel S Terry; Lei Shi; Matthias Quick; Harel Weinstein; Scott C Blanchard; Jonathan A Javitch
Journal:  Nature       Date:  2011-04-24       Impact factor: 49.962

7.  A 40-bp VNTR polymorphism in the 3'-untranslated region of DAT1/SLC6A3 is associated with ADHD but not with alcoholism.

Authors:  Omar Šerý; Ivo Paclt; Ivana Drtílková; Pavel Theiner; Marta Kopečková; Petr Zvolský; Vladimir J Balcar
Journal:  Behav Brain Funct       Date:  2015-06-11       Impact factor: 3.759

8.  MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer.

Authors:  Hua Shen; Lin Wang; Xin Ge; Cheng-Fei Jiang; Zhu-Mei Shi; Dong-Mei Li; Wei-Tao Liu; Xiaobo Yu; Yong-Qian Shu
Journal:  Oncotarget       Date:  2016-04-12

9.  The microRNA.org resource: targets and expression.

Authors:  Doron Betel; Manda Wilson; Aaron Gabow; Debora S Marks; Chris Sander
Journal:  Nucleic Acids Res       Date:  2007-12-23       Impact factor: 16.971

10.  Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma.

Authors:  Xia Li; Yuexin Liu; Kirsi J Granberg; Qinhao Wang; Lynette M Moore; Ping Ji; Joy Gumin; Erik P Sulman; George A Calin; Hannu Haapasalo; Matti Nykter; Ilya Shmulevich; Gregory N Fuller; Frederick F Lang; Wei Zhang
Journal:  Oncogene       Date:  2014-04-21       Impact factor: 9.867

View more
  21 in total

1.  Special Topic on Mental Health and Addiction.

Authors:  Lin Lu; Wenhua Zhou
Journal:  Neurosci Bull       Date:  2016-11-21       Impact factor: 5.203

2.  Inhibition of KLF7-Targeting MicroRNA 146b Promotes Sciatic Nerve Regeneration.

Authors:  Wen-Yuan Li; Wei-Ting Zhang; Yong-Xia Cheng; Yan-Cui Liu; Feng-Guo Zhai; Ping Sun; Hui-Ting Li; Ling-Xiao Deng; Xiao-Feng Zhu; Ying Wang
Journal:  Neurosci Bull       Date:  2018-01-22       Impact factor: 5.203

Review 3.  Drug addiction: a curable mental disorder?

Authors:  Jian-Feng Liu; Jun-Xu Li
Journal:  Acta Pharmacol Sin       Date:  2018-10-31       Impact factor: 6.150

4.  Regulation of the Glycine Transporter GLYT1 by microRNAs.

Authors:  Esperanza Jiménez; Dolores Piniella; Cecilio Giménez; Francisco Zafra
Journal:  Neurochem Res       Date:  2021-01-23       Impact factor: 3.996

5.  Silencing protein kinase C ζ by microRNA-25-5p activates AMPK signaling and inhibits colorectal cancer cell proliferation.

Authors:  Shihu Zhang; Yiyang Zhang; Qing Cheng; Zhaoqun Ma; Guanwen Gong; Zhengming Deng; Kun Xu; Gaoyuan Wang; Yousong Wei; Xiaoping Zou
Journal:  Oncotarget       Date:  2017-06-27

6.  DlgR2 knockdown boosts dendritic cell activity and inhibits hepatocellular carcinoma tumor in-situ growth.

Authors:  Zhen Lu; Yun-Hong Xia; Min Zhao; Bing Zhang; Wen-Ting Dai; Lu Ding; Li-Xia Hu; Jin-Ling Bi; Guo-Lin Jiang
Journal:  Oncotarget       Date:  2017-07-05

7.  Targeting cyclophilin-D by compound 19 protects neuronal cells from oxygen glucose deprivation/re-oxygenation.

Authors:  Jinyu Zheng; Enhui Cui; Haikou Yang; Mao Li; Jing Zhou; Ming Yan; Jian Sun; De-Rong Tang
Journal:  Oncotarget       Date:  2017-10-06

8.  Association study and a systematic meta-analysis of the VNTR polymorphism in the 3'-UTR of dopamine transporter gene and attention-deficit hyperactivity disorder.

Authors:  Edna Grünblatt; Anna Maria Werling; Alexander Roth; Marcel Romanos; Susanne Walitza
Journal:  J Neural Transm (Vienna)       Date:  2019-03-28       Impact factor: 3.575

9.  Tumor-specific hepatic stellate cells (tHSCs) induces DIgR2 expression in dendritic cells to inhibit T cells.

Authors:  Yun-Hong Xia; Zhen Lu; Min Zhao; Wen-Ting Dai; Lu Ding; Li-Xia Hu; Guo-Lin Jiang
Journal:  Oncotarget       Date:  2017-07-05

10.  Enhancer Function of MicroRNA-3681 Derived from Long Terminal Repeats Represses the Activity of Variable Number Tandem Repeats in the 3' UTR of SHISA7.

Authors:  Hee-Eun Lee; Sang-Je Park; Jae-Won Huh; Hiroo Imai; Heui-Soo Kim
Journal:  Mol Cells       Date:  2020-07-31       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.